Transient Global Amnesia

Back

Background

Transient global amnesia (TGA) has been a well-described phenomenon for more than 40 years. Clinically, it manifests with a paroxysmal, transient loss of memory function. Immediate recall ability is preserved, as is remote memory; however, patients experience striking loss of memory for recent events and an impaired ability to retain new information. In some cases, the degree of retrograde memory loss is mild.

Many patients are anxious or agitated and may repeatedly ask questions concerning transpiring events. Upon mental status examination, language function is preserved, which indicates a preservation of semantic and syntax memory. Attention is spared, visual-spatial skills are intact, and social skills are retained. Symptoms typically last less than 24 hours. As the syndrome resolves, the amnesia improves, but the patient may be left with a distinct lapse of recollection for events during the attack.

Generally, TGA is a solitary event, however, patients can experience more than one event with very similar symptoms and recovery.

Pathophysiology

The precise pathophysiology of transient global amnesia is not clear. The findings reported with positron emission tomography (PET), diffusion-weighted MRI (DWI), single photon emission computed tomography (SPECT) and MR spectroscopy (MRS) have indicated various brain regions that are affected in TGA.

Overall, the variety of findings on functional imaging studies may support the notion that TGA is a syndrome with not only a variety of precipitating causes but also of differing mechanisms.

Epidemiology

Frequency

United States

Based on data from Rochester, Minnesota, Miller et al determined an incidence of 5.2 cases per 100,000 population. However, among individuals older than 50 years, the incidence was 23.5 cases per 100,000 population per year.[9]

International

Estimates vary, but Matiea-Guiu et al found a lower incidence in Alcoi, Spain, of 2.9 cases per 100,000 population.[10] On the other hand, Lauria et al found an incidence of 10 cases per 100,000 population in Belluno, Italy.[11]

Mortality/Morbidity

As the name implies, transient global amnesia symptoms are transient.

The mean annual recurrence rate is thought to be low (approximately 4-5%). However, in the study by Miller et al, the calculated recurrence rate could be as high as 24% over a lifetime depending on inclusion criteria.[9] These occasional recurrences usually involve no long-term morbidity or death.

If transient ischemic attack (TIA) is suspected, then the patient should be evaluated for stroke risk factors. Likewise, if a seizure is suspected, appropriate testing should be initiated.

Age- and sex-related demographics

The typical age of occurrence is older than 50 years.

No sex predilection has been observed. However, one study found that particular triggers may be associated with men and women. For men, transient global amnesia occurs more often after a physical precipitating event. In women, episodes may be more associated with emotional precipitating events, a history of anxiety, or pathological personality.

 

History

Transient global amnesia (TGA) is a well-described syndrome, but one whose exact etiology is not yet completely understood.

TGA specifically affects memory function. As mentioned previously, patients can register information, but retentive memory ability is affected dramatically.

Many mechanisms have been proposed, but no single cause can explain fully all the features of TGA. These include migraine variant, temporal lobe seizure, and TIA. If a patient is young or has repeated attacks, then the possibility of seizure or even migraine is higher. Some authors have stated that patients with TGA have age and risk factor profiles similar to those of patients with stroke or TIA,[12] but patients with TGA have a low incidence of strokes on follow-up.

There is a demonstrated association between TGA and migraine. In one nationwide cohort study, migraine was associated with an increased risk of TGA, particularly in female patients aged 40-60 years.[13]

Precipitants of TGA frequently include physical exertion, overwhelming emotional stress, pain, cold-water exposure, sexual intercourse, and Valsalva maneuver. These triggers may have a common physiologic feature: increased venous return to the superior vena cava.

The effects of drugs must be considered. For instance, sedative-hypnotic medications, either over-the-counter or prescribed for sleep (especially if used in conjunction with a transoceanic flight), or premedication with midazolam for medical procedures, may cause similar symptoms. Excessive alcohol can cause a blackout phenomenon. Hence, any history of drug-related amnesia may help clarify mitigating causes.

Sporadic reports of TGA occur very rarely in a variety of circumstances such as dobutamine-atropine stress echocardiography, infusion of DMSO-cryopreserved autologous peripheral blood stem cells, breathing of hyperoxic mixtures (Nitrox) in diving, intrathecal baclofen treatments, and withdrawal symptoms from a beta-blocker. In this report, the authors suggest that vasospasm might be an etiology versus venous conjestion.[14]

Social history and family history is relevant. Pantoni et al found that patients with TGA have a higher incidence of personal or family background of psychiatric conditions compared with patients who have had a TIA.[15] Prognostically, patients with TGA are less likely to experience a cardiovascular or cerebrovascular event compared with patients who have had a TIA.

Physical

Neurologic examination of the patient typically fails to demonstrate any abnormalities (other than memory dysfunction).

If any lateralizing or focal findings are noted on the examination, then the diagnosis of transient global amnesia should be questioned.

Causes

The exact mechanism that produces transient global amnesia is unclear.

The most compelling evidence in favor of migraine is that patients who suffer from a TGA event have a slightly higher incidence of a previous migraine. However, patients with TGA rarely report an associated headache. They also do not report nausea, photophobia, or phonophobia.

Seizure (eg, temporal lobe) is unlikely. TGA events are not associated with alteration of consciousness or stereotypical movements. EEG does not demonstrate epileptiform activity.

TIA as indicative of cerebrovascular disease is unlikely. Studies have demonstrated that patients with TGA have fewer cerebrovascular risk factors than those with known cerebrovascular or coronary artery disease. The prognosis for TGA is often better than for TIAs.

One theory proposed by Lewis is that venous congestion causes disrupted blood flow to the thalamic or mesial temporal structures.[16] More recently, one study used cranial 3-dimensional time-of-flight (TOF) MR angiography (MRA) to try to detect any intracranial retrograde venous flow in 10 patients with TGA. By using left brachiocephalic vein occlusion, retrograde intracranial venous flow was found only in patients (5 of 10) versus controls. The authors suggest that this may indicate that patients have an impairment of cerebral venous outflow that make them at risk for a TGA event.

The frequently cited triggers for TGA can increase either sympathetic activity and/or intrathoracic pressure. This, in turn, could cause back-pressure in the jugular venous system, disrupting intracranial arterial flow with secondary venous congestion/ischemia to memory areas in the brain.

Conditions predisposing to this scenario might include venous anatomy anomalies, integrity of jugular vein valves, timing of the trigger, and severity of the inciting event. In support of the above concept of venous congestion are Schreiber et al's finding of a higher prevalence of internal jugular vein valve incompetence in patients with TGA versus normal controls and Cejas et al's similar findings.[17, 18] However, the authors of this study could find no particular internal jugular vein valve incompetence associated venous circulatory patterns that could indicate a direct cause/effect with TGA.[17]

Laboratory Studies

Lab studies may include the following:

When a patient initially presents with transient global amnesia, stroke must be ruled out. This can be done using screening clotting tests, including prothrombin time (PT), activated partial throboplastin time (aPTT), and INR.

Imaging Studies

Brain MRI and/or CT scan

Any patient presenting with features of transient global amnesia should receive an imaging test to rule out a stroke possibility, especially if significant risk factors are present.

MRI with DWI can readily demonstrate acute ischemic changes early and guide management. In one study, higher resolution DWI imaging increased detection of hippocampal lesions in 27 patients with transient global amnesia, from 11 with standard resolution MRI to 22 with high resolution MRI.[19] If an MRI cannot be obtained readily, then at least a CT scan should be done initially if the patient is presenting to an emergency department.

Other Tests

ECG, EEG

These tests are important if the diagnosis of TGA is in doubt. If symptoms have occurred more than once, then at least a routine EEG should be done to help investigate a seizure possibility by demonstrating any interictal activity.

Medical Care

Once transient global amnesia (TGA) is diagnosed, provide reassurance to the patient and schedule at least one follow-up visit with a neurologist.

Activity

Avoid activities that could produce an unusual increase in intrathoracic pressure.

What is transient global amnesia (TGA)?What is the pathophysiology of transient global amnesia (TGA)?What is the incidence of transient global amnesia (TGA) in the US?What is the global incidence of transient global amnesia (TGA)?What is the recurrence rate for transient global amnesia (TGA)?What assessments are needed in patients with suspected transient global amnesia (TGA)?How does the incidence of transient global amnesia (TGA) vary by sex and age?What should be the focus of history in the evaluation of transient global amnesia (TGA)?Which neurologic findings are characteristic of transient global amnesia (TGA)?What are the causes of transient global amnesia (TGA)?What are the differential diagnoses for Transient Global Amnesia?What is the role of lab studies in the workup of transient global amnesia (TGA)?What is the role of imaging studies in the workup of transient global amnesia (TGA)?What is the role of EEG in the workup of transient global amnesia (TGA)?How is transient global amnesia (TGA) treated?Which activity modifications used in the treatment of transient global amnesia (TGA)?

Author

Roy Sucholeiki, MD, Director, Comprehensive Seizure and Epilepsy Program, The Neurosciences Institute at Central DuPage Hospital

Disclosure: Nothing to disclose.

Specialty Editors

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Howard S Kirshner, MD, Professor of Neurology, Psychiatry and Hearing and Speech Sciences, Vice Chairman, Department of Neurology, Vanderbilt University School of Medicine; Director, Vanderbilt Stroke Center; Program Director, Stroke Service, Vanderbilt Stallworth Rehabilitation Hospital; Consulting Staff, Department of Neurology, Nashville Veterans Affairs Medical Center

Disclosure: Nothing to disclose.

Chief Editor

Helmi L Lutsep, MD, Professor and Vice Chair, Department of Neurology, Oregon Health and Science University School of Medicine; Associate Director, OHSU Stroke Center

Disclosure: Medscape Neurology Editorial Advisory Board for: Stroke Adjudication Committee, CREST2; Physician Advisory Board for Coherex Medical; National Leader and Steering Committee Clinical Trial, Bristol Myers Squibb; Consultant, Abbott Vascular, Inc. .

Additional Contributors

Carmel Armon, MD, MSc, MHS, Chair, Department of Neurology, Assaf Harofeh Medical Center, Tel Aviv University Sackler Faculty of Medicine, Israel

Disclosure: Received research grant from: Neuronix Ltd, Yoqnea'm, Israel<br/>Received income in an amount equal to or greater than $250 from: JNS - Associate Editor. UpToDate - Author Royalties.

References

  1. Yang Y, Kim JS, Kim S, Kim YK, Kwak YT, Han IW. Cerebellar Hypoperfusion during Transient Global Amnesia: An MRI and Oculographic Study. J Clin Neurol. 2009 Jun. 5(2):74-80. [View Abstract]
  2. Liang JF, Shen AL, Lin SK. Bilateral hippocampal abnormalities on diffusion-weighted MRI in transient global amnesia: report of a case. Acta Neurol Taiwan. 2009 Jun. 18(2):127-9. [View Abstract]
  3. Eustache F, Desgranges B, Petit-Taboué MC, et al. Transient global amnesia: implicit/explicit memory dissociation and PET assessment of brain perfusion and oxygen metabolism in the acute stage. J Neurol Neurosurg Psychiatry. 1997 Sep. 63(3):357-67. [View Abstract]
  4. Strupp M, Bruning R, Wu RH, et al. Diffusion-weighted MRI in transient global amnesia: elevated signal intensity in the left mesial temporal lobe in 7 of 10 patients. Ann Neurol. 1998 Feb. 43(2):164-70. [View Abstract]
  5. Winbeck K, Etgen T, von Einsiedel HG, et al. DWI in transient global amnesia and TIA: proposal for an ischaemic origin of TGA. J Neurol Neurosurg Psychiatry. 2005 Mar. 76(3):438-41. [View Abstract]
  6. Nakada T, Kwee IL, Fujii Y, Knight RT. High-field, T2 reversed MRI of the hippocampus in transient global amnesia. Neurology. 2005 Apr 12. 64(7):1170-4. [View Abstract]
  7. Yamane Y, Ishii K, Shimizu K, Sofue K, Yoshikawa T, Miyamoto N, et al. Global cerebral hypoperfusion in a patient with transient global amnesia. J Comput Assist Tomogr. 2008 May-Jun. 32(3):415-7. [View Abstract]
  8. Bartsch T, Alfke K, Wolff S, Rohr A, Jansen O, Deuschl G. Focal MR spectroscopy of hippocampal CA-1 lesions in transient global amnesia. Neurology. 2008 Mar 25. 70(13):1030-5. [View Abstract]
  9. Miller JW, Petersen RC, Metter EJ, et al. Transient global amnesia: clinical characteristics and prognosis. Neurology. 1987 May. 37(5):733-7. [View Abstract]
  10. Matias-Guiu J, Blanquer J, Falip R, et al. Incidence of transient global amnesia in a Alcoi (Spain). Acta Neurol Scand. 1992 Aug. 86(2):221. [View Abstract]
  11. Lauria G, Gentile M, Fassetta G, et al. Incidence of transient global amnesia in the Belluno province, Italy: 1985 through 1995. Results of a community-based study. Acta Neurol Scand. 1997 May. 95(5):303-10. [View Abstract]
  12. Shuping JR, Rollinson RD, Toole JF. Transient global amnesia. Ann Neurol. 1980 Mar. 7(3):281-85. [View Abstract]
  13. Lin KH, Chen YT, Fuh JL, Li SY, Chen TJ, Tang CH, et al. Migraine is associated with a higher risk of transient global amnesia: a nationwide cohort study. Eur J Neurol. 2014 May. 21(5):718-24. [View Abstract]
  14. Saura D, Peñafiel P, Morales A, Albert L, Martínez F, de la Morena G. Transient global amnesia after dobutamine--atropine stress echocardiography. Eur J Echocardiogr. 2008 Jul. 9(4):567-8. [View Abstract]
  15. Pantoni L, Bertini E, Lamassa M, et al. Clinical features, risk factors, and prognosis in transient global amnesia: a follow-up study. Eur J Neurol. 2005 May. 12(5):350-6. [View Abstract]
  16. Lewis SL. Aetiology of transient global amnesia. Lancet. 1998 Aug 1. 352(9125):397-9. [View Abstract]
  17. Schreiber SJ, Doepp F, Klingebiel R, Valdueza JM. Internal jugular vein valve incompetence and intracranial venous anatomy in transient global amnesia. J Neurol Neurosurg Psychiatry. 2005 Apr. 76(4):509-13. [View Abstract]
  18. Cejas C, Cisneros LF, Lagos R, Zuk C, Ameriso SF. Internal Jugular Vein Valve Incompetence Is Highly Prevalent in Transient Global Amnesia. Stroke. 2009 Nov 19. [View Abstract]
  19. Choi BS, Kim JH, Jung C, Kim SY. High-Resolution Diffusion-Weighted Imaging Increases Lesion Detectability in Patients with Transient Global Amnesia. AJNR Am J Neuroradiol. 2012 Apr 26. [View Abstract]
  20. Adams RD, Victor M, Ropper AH. Transient global amnesia. Principles of Neurology. New York: McGraw-Hill; 1997: 429-30.
  21. Ay H, Furie KL, Yamada K, Koroshetz WJ. Diffusion-weighted MRI characterizes the ischemic lesion in transient global amnesia. Neurology. 1998 Sep. 51(3):901-3. [View Abstract]
  22. Chung CP, Hsu HY, Chao AC, et al. Detection of intracranial venous reflux in patients of transient global amnesia. Neurology. 2006 Jun 27. 66(12):1873-7. [View Abstract]
  23. Grande LA, Loeser JD, Samii A. Recurrent transient global amnesia with intrathecal baclofen. Anesth Analg. 2008 Apr. 106(4):1284-7, table of contents. [View Abstract]
  24. Hinge HH, Jensen TS, Kjaer M, et al. The prognosis of transient global amnesia. Results of a multicenter study. Arch Neurol. 1986 Jul. 43(7):673-6. [View Abstract]
  25. Lauria G, Gentile M, Fassetta G, et al. Transient global amnesia and transient ischemic attack: a community- based case-control study. Acta Neurol Scand. 1998 Jun. 97(6):381-5. [View Abstract]
  26. Otrock ZK, Beydoun A, Barada WM, Masroujeh R, Hourani R, Bazarbachi A. Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells. Haematologica. 2008 Mar. 93(3):e36-7. [View Abstract]
  27. Quinette P, Guillery-Girard B, Dayan J, et al. What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain. 2006. 129:1640-58. [View Abstract]
  28. Schmidtke K, Ehmsen L. Transient global amnesia and migraine. A case control study. Eur Neurol. 1998 Jul. 40(1):9-14. [View Abstract]
  29. Spigno F, De Lucchi M, Migliazzi L, Cocito L. Transient global amnesia after breathing hyperoxic mixtures in otherwise regular dives. Clin Neurol Neurosurg. 2008 Mar. 110(3):259-61. [View Abstract]
  30. Vyhnálek M, Bojar M, Jerabek J, Hort J. Long lasting recurrent familiar transient global amnesia after betablocker treatment withdrawal: case report. Neuro Endocrinol Lett. 2008 Feb. 29(1):44-6. [View Abstract]
  31. Zweifler RM. Management of acute stroke. South Med J. 2003 Apr. 96(4):380-5. [View Abstract]